Fbxo10em2Ccg
Endonuclease-mediated Allele Detail
|
Symbol: |
Fbxo10em2Ccg |
Name: |
F-box protein 10; endonuclease-mediated mutation 2, Christopher C Goodnow |
MGI ID: |
MGI:6721015 |
Synonyms: |
Fbxo10frameshift, Fbxo10fs, Fbxo10KO |
Gene: |
Fbxo10 Location: Chr4:45034248-45084555 bp, - strand Genetic Position: Chr4, 23.68 cM
|
Alliance: |
Fbxo10em2Ccg page
|
|
|
Allele Type: |
|
Endonuclease-mediated (Null/knockout) |
Mutation: |
|
Intragenic deletion
|
|
|
Mutation details: CRISPR/Cas9 technology generated a 4 nucleotide deletion (GCCG) in codons 55 and 56 within exon 2, changing the cysteine 55 codon to serine and creating a reading frame shift and premature stop codon after 55 codons (c.del285_288; p.C55Sfs*55). The frame shift deletion does not create a new splice donor site and there is no evidence of alternative splice forms that skip exon 2 and thus is expected to create a null allele. However, antibodies to check for protein expression are not available.
(J:307413)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Fbxo10 Mutation: |
49 strains or lines available
|
|
Original: |
J:307413 Masle-Farquhar E, et al., Loss-of-function of Fbxo10, encoding a post-translational regulator of BCL2 in lymphomas, has no discernible effect on BCL2 or B lymphocyte accumulation in mice. PLoS One. 2021;16(4):e0237830 |
All: |
1 reference(s) |
|